FDA to hold drug compounding listening session

FDA will hold a drug compounding annual listening session, virtually, from 9-11 a.m. ET on June 17. This listening session is an opportunity for stakeholders to voice their views on compounding to the FDA. NCPA will speak at the meeting and will coordinate efforts and topics of discussion with the Alliance for Pharmacy Compounding.